Quick Answer
Solid Biosciences Inc. reported Total Revenue of $8.09 million for fiscal year 2022.
Solid Biosciences Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2022 | $8.09M | -40.6% |
| 2021 | $13.62M | — |
| 2020 | $0.00 | — |
| 2019 | $0.00 | — |
| 2018 | $0.00 | — |
| 2017 | $0.00 | — |
| 2016 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2020 | $0.00 | — | — |
| June 30, 2020 | $0.00 | — | — |
| March 31, 2020 | $0.00 | — | — |
| September 30, 2019 | $0.00 | — | — |
| June 30, 2019 | $0.00 | — | — |
| March 31, 2019 | $0.00 | — | — |
| September 30, 2018 | $0.00 | — | — |
| June 30, 2018 | $0.00 | — | — |
- Solid Biosciences Inc. showed a decrease of -40.6% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Solid Biosciences Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on March 23, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: